In Silico Drug Screening Analysis against the Overexpression of PGAM1 Gene in Different Cancer Treatments

Table 3

Prediction of genetic toxicity endpoints of candidate compounds.

Sr. no.	Compound name	Cytotoxicity	Probability	Mutagenicity	Probability
1	N-Nitrosohexamethyleneimine	Inactive	0.60	Inactive	0.90
2	Subtrifloralactone-K	Inactive	0.50	Inactive	0.57
3	Kanzonol-N	Inactive	0.76	Inactive	0.66